Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Surgery
Published in: European Surgery 4/2016

01-08-2016 | Original Article

Retrospective analysis of prognostic factors in patients with duodenal adenocarcinoma

Authors: P. Téoule, M. Distler, M. Niedergethmann, T. Gaiser, F. Rückert, R. Grützmann, T. J. Wilhelm

Published in: European Surgery | Issue 4/2016

Login to get access

Summary

Background

Sporadic duodenal cancer is a rare cancer entity. Therefore, the prognostic significance of clinicopathologic features is unknown. This study aimed to identify prognostic factors and compare survival with other tumour entities of the same anatomical region.

Methods

We retrospectively studied medical records of 22 patients with duodenal adenocarcinoma (DAC), who underwent resection in two German centres for pancreatic surgery (1994–2012). Mean time of follow-up was 51.3 months. Predictive factors were evaluated by log rank analysis.

Results

Whipple surgery was performed in seven cases (31.8 %), pylorus preserving pancreaticoduodenectomy in 14 cases (63.6 %) and partial duodenectomy in one case (4.5 %). R0-resection was achieved in 86.4 %. In all, 50% of our patients had nodal positive disease. Overall morbidity was 59.1 % and perioperative mortality was 9.1 %. Survival after resection was 63.6 % and 59.0 % (3- and 5-years). There was no significant survival difference between patients with DAC and ampullary cancer, but survival was longer compared with patients with pancreatic cancer.

Conclusions

Mortality seems to be high after resection of DAC. However, radical surgery should be performed due to the high number of patients with nodal positive disease. No definite prognostic factors were identified. The prognosis after resection of duodenal cancer can be compared with patients with ampullary cancer.
Literature
1.
Sexe RB, Wade TP, Virgo KS, Johnson FE. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer. 1996;77(2):251–4.CrossRefPubMed
2.
3.
Hurtuk MG, Devata S, Brown KM, Oshima K, Aranha GV, Pickleman J, et al. Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection? Am J Surg. 2007;193(3):319–24.(discussion 324–5).CrossRefPubMed
4.
Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg. 1998;2(1):79–87.CrossRefPubMed
5.
Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518–26.CrossRefPubMed
6.
Swartz MJ, Hughes MA, Frassica DA, Herman J, Yeo CJ, Riall TS, et al. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007;142(3):285–8.CrossRefPubMed
7.
Santoro E, Sacchi M, Scutari F, Carboni F, Graziano F. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients. Hepatogastroenterology. 1997;44(16):1157–63.PubMed
8.
Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg. 2000;179(1):37–41.CrossRefPubMed
9.
Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW. Prognostic factors for primary duodenal adenocarcinoma. World J Surg. 2008;32(10):2246–52.CrossRefPubMed
10.
Lee SY, Lee JH, Hwang DW, Kim SC, Park K-M, Lee Y-J. Long-term outcomes in patients with duodenal adenocarcinoma. ANZ J Surg. 2013.
11.
Han S-L, Cheng J, Zhou H-Z, Zeng Q-Q, Lan S-H. The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer. 2010;41(4):243–7.CrossRefPubMed
12.
Cecchini S, Correa-Gallego C, Desphande V, Ligorio M, Dursun A, Wargo J, et al. Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma. J Gastrointest Surg. 2012;16(1):113–20. (discussion 120).CrossRefPubMed
13.
Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, et al. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg. 2012;16(4):682–91.CrossRefPubMed
14.
Malleo G, Tonsi A, Marchegiani G, Casarotto A, Paiella S, Butturini G, et al. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. Langenbecks Arch Surg. 2013;398(2):287–94.CrossRefPubMed
15.
Struck A, Howard T, Chiorean EG, Clarke JM, Riffenburgh R, Cardenes HR. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol. 2009;100(2):144–8.CrossRefPubMed
16.
Rose DM, Hochwald SN, Klimstra DS, Brennan MF. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg. 1996;183(2):89–96.PubMed
17.
Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KCP. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol. 2004;11(4):380–6.CrossRefPubMed
18.
Distler M, Rückert F, Hunger M, Kersting S, Pilarsky C, Saeger H-D, et al. Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma. BMC Surg. 2013;13:12.CrossRefPubMedPubMedCentral
19.
Rückert F, Kersting S, Fiedler D, Distler M, Dobrowolski F, Pilarsky C, et al. Chronic pancreatitis: early results of pancreatoduodenectomy and analysis of risk factors. Pancreas. 2011;40(6):925–30.CrossRefPubMed
20.
Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142(1):20–5.CrossRefPubMed
21.
Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142(5):761–8.CrossRefPubMed
22.
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.CrossRefPubMed
23.
Kleinerman J, Yardumian K, Tamaki H. Primary carcinoma of the duodenum. Ann Intern Med. 1950;32:451–65.CrossRef
24.
25.
Rückert F, Pilarsky C, Grützmann R. Serum tumor markers in pancreatic cancer-recent discoveries. Cancers (Basel). 2010;2(2):1107–24.CrossRef
26.
Grützmann R, Rückert F, Hippe-Davies N, Distler M, Saeger H-D. Evaluation of the International Study Group of Pancreatic Surgery definition of post-pancreatectomy hemorrhage in a high-volume center. Surgery. 2012;151(4):612–20.CrossRefPubMed
27.
Allema JH, Reinders ME, van Gulik TM, Koelemay MJ, Van Leeuwen DJ, de Wit LT, et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 1995;75(8):2069–76.CrossRefPubMed
28.
Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234(6):758–68.CrossRefPubMedPubMedCentral
29.
Jabbour SK, Mulvihill D. Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol. 2014;24(2):85–93.CrossRefPubMed
Metadata
Title
Retrospective analysis of prognostic factors in patients with duodenal adenocarcinoma
Authors
P. Téoule
M. Distler
M. Niedergethmann
T. Gaiser
F. Rückert
R. Grützmann
T. J. Wilhelm
Publication date
01-08-2016
Publisher
Springer Vienna
Published in
European Surgery / Issue 4/2016
Print ISSN: 1682-8631
Electronic ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-015-0374-0

Other articles of this Issue 4/2016

European Surgery 4/2016 Go to the issue

original article

Morbidity and mortality of colorectal cancer surgery in octogenarians

original article

Clinical and inflammatory response to first ileocolic resection for Crohn’s disease

case report

Gastric carcinoma presenting with severe rectal stenosis: ‘Schnitzler’s metastasis’: case report and review of the literature

case report

Treatment of Boerhaave’s Syndrome: Specialized Esophago-Gastric Unit Experience on Twelve Patients

Editorial

Tuff, tailored and tiny: under the skies of surgery

short communication

The cleft lift procedure for complex pilonidal disease